AmerisourceBergen

RANK21

Drug distribution giant AmerisourceBergen fell four spots on the Global 500 from last year. Like its large rivals in the business, the company continues to wrestle with lawsuits regarding its alleged role in the opioid crisis while enduring criticism from shareholders. Still, revenue increased by 12.7% to $214 billion for the fiscal year ended September 2021. AmerisourceBergen also unveiled a new global headquarters in Conshohocken, Pa.